Yan Wang

Yan Wang

Auto-generated profile, based on publicly available information

Yan Wang

Department of Neurology, School of Medicine, University of California, Davis, Sacramento, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Cell Reports
Verified
Journal Article
Open access
YWYan Wang
Yan Wang
YZYanhong Zhang
Yanhong Zhang
SZSheng Zhang
Sheng Zhang
BKBokyung Kim
Bokyung Kim
VHVanessa L. Hull
Vanessa L. Hull
FGFuzheng Guo
Fuzheng Guo
The function of poly(ADP-ribosyl) polymerase 1 (PARP1) in myelination and remyelination of the central nervous system (CNS) remains enigmatic. Here, we report that PARP1 is an intrinsic driver for oligodendroglial development and myelination. Genetic PARP1 depletion impairs the differentiation of oligodendrocyte progenitor cells (OPCs) into oligodendrocytes and impedes CNS myelination. Mechanistically, PARP1-mediated PARylation activity is not only necessary but also sufficient for OPC differentiation. At the molecular level, we identify the RNA-binding protein Myef2 as a PARylated target, which controls OPC differentiation through the PARylation-modulated derepression of myelin protein expression. Furthermore, PARP1’s enzymatic activity is necessary for oligodendrocyte and myelin regeneration after demyelination. Together, our findings suggest that PARP1-mediated PARylation activity may be a potential therapeutic target for promoting OPC differentiation and remyelination in neurological disorders characterized by arrested OPC differentiation and remyelination failure such as multiple sclerosis.


22 November 2021 in Biological Reviews
Verified
Journal Article
Closed access
PDF file
YWYan Wang
Yan Wang
FGFuzheng Guo
Fuzheng Guo

23 August 2023 in Glia
Verified
Journal Article
Open access
VHVanessa L. Hull
Vanessa L. Hull
YWYan Wang
Yan Wang
TBTravis Burns
Travis Burns
SSSarah Sternbach
Sarah Sternbach
SGShuaishuai Gong
Shuaishuai Gong
DPDavid Pleasure
David Pleasure
Canavan disease (CD) is a recessively inherited pediatric leukodystrophy resulting from inactivating mutations to the oligodendroglial enzyme aspartoacylase (ASPA). ASPA is responsible for hydrolyzing the amino acid derivative N-acetyl-L-aspartate (NAA), and without it, brain NAA concentrations increase by 50% or more. Infants and children with CD present with progressive cognitive and motor delays, cytotoxic edema, astroglial vacuolation, and prominent spongiform brain degeneration. ASPA-deficient CD mice (Aspa(nur7/nur7)) present similarly with elevated NAA, widespread astroglial dysfunction, ataxia, and Purkinje cell (PC) dendritic atrophy. Bergmann glia (BG), radial astrocytes essential for cerebellar development, are intimately intertwined with PCs, where they regulate synapse stability, functionality, and plasticity. BG damage is common to many neurodegenerative conditions and frequently associated with PC dysfunction and ataxia. Here, we report that, in CD mice, BG exhibit significant morphological alterations, decreased structural associations with PCs, loss of synaptic support proteins, and altered calcium dynamics. We also find that BG dysfunction predates cerebellar vacuolation and PC damage in CD mice. Previously, we developed an antisense oligonucleotide (ASO) therapy targeting Nat8l (N-acetyltransferase-8-like, "Nat8l ASO") that inhibits the production of NAA and reverses ataxia and PC atrophy in CD mice. Here, we show that Nat8l ASO administration in adult CD mice also leads to BG repair. Furthermore, blocking astroglial uptake of NAA is neuroprotective in astroglia-neuron cocultures exposed to elevated NAA. Our findings suggest that restoration of BG structural and functional integrity could be a mechanism for PC regeneration and improved motor function.

29 August 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
YWYan Wang
Yan Wang
MZMeina Zhu
Meina Zhu
JPJoohyun Park
Joohyun Park
HKHyun Kyu Kim
Hyun Kyu Kim
GXGe Xiong
Ge Xiong
FGFuzheng Guo
Fuzheng Guo
Oligodendrocytes (OLs) are brain cells that make myelin, the insulating sheath that supports nerve signal transmission. Although oligodendrocyte dysfunction is common in the central nervous system (CNS), how these cells respond to injury remains incompletely understood. Here we show, using mouse models and mouse tissue analyses, that OLs respond to demyelinating diseases by increasing the expression and secretion of serine protease inhibitor clade A member 3N (SERPINA3N). This transition of homeostatic OLs to Serpina3n-expressing OLs (SerpinOLs) occurs not only in demyelinating disease, but also after stroke, endotoxin-induced injury, neurodegeneration, traumatic injury, and healthy aging. Mechanistically, direct injury to OLs, rather than inflammation alone, drives the transition. Phenotypically, SerpinOLs show inflammatory and immune-regulatory features and activation of signal transducer and activator of transcription 3 (STAT3), which is required for SERPINA3N induction. Functionally, SerpinOLs amplify neuroinflammation and glial activation toward pro-inflammatory and neurodegenerative states. Together, SerpinOLs represent a common population of injury-transduced OLs that contributes to CNS pathology beyond myelin production.

12 October 2023 in Glia
Verified
Journal Article
Closed access
VHVanessa L. Hull
Vanessa L. Hull
YWYan Wang
Yan Wang
TBTravis Burns
Travis Burns
SSSarah Sternbach
Sarah Sternbach
SGShuaishuai Gong
Shuaishuai Gong
DPDavid Pleasure
David Pleasure